Ting Xiao

959 total citations
29 papers, 689 citations indexed

About

Ting Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ting Xiao has authored 29 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Ting Xiao's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ting Xiao is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ting Xiao collaborates with scholars based in China, Australia and United States. Ting Xiao's co-authors include Honggang Zhou, Cheng Yang, Mingjiang Li, Bo Yang, Xiaohe Li, Yuan Qin, Huijuan Liu, Ronghao Sun, Xiaoping Li and Weidong Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Science Advances and Molecules.

In The Last Decade

Ting Xiao

26 papers receiving 686 citations

Peers

Countries citing papers authored by Ting Xiao

Since Specialization

Citations

This map shows the geographic impact of Ting Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Xiao more than expected).

Fields of papers citing papers by Ting Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Xiao. The network helps show where Ting Xiao may publish in the future.

Co-authorship network of co-authors of Ting Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Xiao. A scholar is included among the top collaborators of Ting Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Xiao. Ting Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chloral Hydrate’s Impact on Brain Development: From Clinical Safety to Molecular Mechanisms 2025 ·Drug Design Development and Therapy ·Pengyi Deng, Chenghao Zhu, (unknown), Lingling Zhu, Ting Xiao, Shuangquan Qu	0
2	Liquid biopsy-derived extracellular vesicle protein biomarkers for diagnosis and prognostic assessment of lung squamous cell carcinoma 2025 ·Cancer Cell International ·(unknown), Na Zhao, (unknown), Yaru Wang, (unknown), (unknown), (unknown), Congcong Ma, Shujun Cheng, Jie Li, Yutao Liu, Ting Xiao	0
3	Deciphering the role of PLCD3 in lung cancer: A gateway to glycolytic reprogramming via PKC-Rap1 activation 2024 ·Heliyon ·Liang Zhang, Mingjiang Li, (unknown), Ting Xiao, Honggang Zhou, (unknown), Ping Wang	1
4	Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma 2023 ·Pulmonary Pharmacology & Therapeutics ·Shanshan Chen, (unknown), Ronghao Sun, (unknown), Chunya Lu, Zi‐Hui Zhang, Ting Xiao, (unknown), Honggang Zhou	3
5	Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway 2023 ·Molecules ·(unknown), Jingjing Liang, Jianwei Zhang, Zhichao Liu, Miao Yang, (unknown), Shimeng Li, (unknown), (unknown), Ting Xiao, Xiaohe Li, Cheng Yang	22
6	Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo study 2023 ·European Journal of Pharmacology ·Ting Xiao, (unknown), (unknown), (unknown), Ronghao Sun, (unknown), Jingjing Gao, Shanshan Chen, (unknown), Luqing Wei, (unknown), Cheng Yang, Guang Yang, Honggang Zhou	7
7	PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling 2022 ·Science Advances ·Shaoyan Gao, Xiaohe Li, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ting Xiao, Hui Huang, (unknown), Wen Ning, Guang Yang, Cheng Yang, Honggang Zhou	60
8	Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways 2022 ·Frontiers in Pharmacology ·Hailong Li, Jinhe Li, Ting Xiao, (unknown), Ying Yang, (unknown), Ge Jin, Hailong Cao, Honggang Zhou, Cheng Yang	12
9	Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation 2021 ·Frontiers in Pharmacology ·Ting Xiao, (unknown), (unknown), Ming Wang, Ronghao Sun, (unknown), (unknown), (unknown), Bo Yang, Jianping Lin, (unknown), (unknown), Cheng Yang, Honggang Zhou	66
10	Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice 2021 ·Inflammation ·Ting Xiao, (unknown), (unknown), Peipei Zhang, (unknown), (unknown), (unknown), Ronghao Sun, Ming Wang, Jianping Lin, Liang Zhang, Mingjiang Li, Dongmei Li, Honggang Zhou, Cheng Yang	30
11	Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis 2021 ·Phytomedicine ·Ting Xiao, (unknown), (unknown), Xiaohe Li, Hao Ruan, Liang Zhang, (unknown), (unknown), (unknown), Ming Wang, Ronghao Sun, Mingjiang Li, Jianping Lin, Dongmei Li, Cheng Yang, (unknown)	39
12	Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway 2020 ·International Immunopharmacology ·(unknown), Xiaohe Li, (unknown), Ting Xiao, Rui Liu, Ming Wang, (unknown), (unknown), (unknown), (unknown), Wen Ning, Honggang Zhou, Cheng Yang	27
13	Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening 2020 ·Virologica Sinica ·Yang Han, Qingyu Yang, Ying Liu, Ting Shu, Yue Li, Ting Xiao, (unknown), Ying Wu, Xi Zhou, Dingyu Zhang	5
14	A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR‐558 2020 ·Molecular Oncology ·(unknown), (unknown), Bo Yang, Ting Xiao, (unknown), Xi Yu, (unknown), Mingjiang Li, Weidong Zhang	27
15	Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p 2019 ·Cell Death and Disease ·Xiaoping Li, Bo Yang, (unknown), Ting Xiao, Liang Zhang, Lei Li, Mingjiang Li, Xuhui Wang, Honggang Zhou, Weidong Zhang	99
16	Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway 2018 ·Respiratory Research ·Xiaohe Li, Ting Xiao, Jiahuan Yang, Yuan Qin, Jingjing Gao, Huijuan Liu, Honggang Zhou	48
17	Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8‐year retrospective single‐institutional study 2017 ·Colorectal Disease ·Lin Xu, Songhua Cai, Ting Xiao, Yun-Fei Chen, (unknown), Bing Wu, Guigao Lin, Xiaowei Sun, Jun Lü, Weixun Zhou, Yi Xiao	17
18	A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer 2012 ·Cancer Letters ·Qiang Shan, Xiaomin Lou, Ting Xiao, Ju Zhang, Huiying Sun, Yanning Gao, Shujun Cheng, (unknown), Ningzhi Xu, Siqi Liu	37
19	Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer 2010 ·Medical Oncology ·(unknown), Ling Li, (unknown), Jianjun Zhang, Ting Xiao, (unknown), (unknown), (unknown), (unknown)	1
20	Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells 2003 ·Journal of Dermatological Science ·Ting Xiao, Shinji Kagami, Hidehisa Saeki, Makoto Sugaya, Takashi Kakinuma, Hideki Fujita, Shoichiro Yano, Hiroshi Mitsui, Hideshi Torii, Mayumi Komine, Akihiko Asahina, Koichiro Nakamura, Kunihiko Tamaki	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact